Details of the Drug

General Information of Drug (ID: DMPJT3V)

• Drug Name: 1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione
• Synonyms: CHEMBL193180; 1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione; Benzil-based compound, 13; SCHEMBL2156255

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 318.17
  Logarithm of the Partition Coefficient (xlogp); 3.5
  Rotatable Bond Count (rotbonds); 3
  Hydrogen Bond Donor Count (hbonddonor); 0
  Hydrogen Bond Acceptor Count (hbondacc); 8
• Chemical Identifiers:
  Formula: C14H4F6O2
  IUPAC Name: 1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione
  Canonical SMILES: C1=C(C=C(C(=C1F)F)F)C(=O)C(=O)C2=CC(=C(C(=C2)F)F)F
  InChI: InChI=1S/C14H4F6O2/c15-7-1-5(2-8(16)11(7)19)13(21)14(22)6-3-9(17)12(20)10(18)4-6/h1-4H
  InChIKey: FMFHXBPXDZLEKC-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 11392969
  TTD ID: D0CN8Z

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Liver carboxylesterase (CES1)	TTMF541	EST1_HUMAN	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Liver carboxylesterase (CES1)	DTT	CES1	3.82E-08	1.86	1.9

References

• [1] Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils. Bioorg Med Chem. 2007 Jun 1;15(11):3801-17.